Nat. Rev. Endocrinol. doi: /nrendo

Slides:



Advertisements
Similar presentations
Eric Sherman Pediatric Endo Fellow Captain, USAF, MC
Advertisements

Subclinical Thyroid Disease
Diabetes and Hypothyroidism
Thyroid and Pregnancy a few interesting clinical considerations Ning-Zi Sun GIM PGY-4.
THYROID DISEASE IN PREGNANCY: TREATING TWO PATIENTS Susan J. Mandel, MD MPH Perelman School of Medicine, University of Pennsylvania.
CASE A- THYROID FUNCTION TESTS MYLINH TRUONG. JEN CRAZE, KELLY STEWART,
Welcome to journal club Subclinical Hypothyroidism Imran Bashir.
Hashimoto’s disease was initially recognized by characteristic histopathological abnormalities in the thyroid gland, different from thyroid cancer but.
Endocrinology Thyroid Function Tests Case F Tu Nguyen Tuan Tran Thi Trang.
FDA Advisory Committee for Pharmaceutical Science—March 13, 2003 Carlos R. Hamilton, Jr. MD, FACE American Association of Clinical Endocrinologists—Vice.
Subclincal Thyroid Disease and the Work-up of a Thyroid Nodule
END Thyroid miscellany Dr SS Nussey © S Nussey and  ios.
Congenital hypothyroidism: what on earth is it? A more ‘progressive’ approach. John Gregory Professor in Paediatric Endocrinology Cardiff University.
Peter Deman Henny Janssen.  Subclinical hypothyroidism is frequently found in adults with Down syndrome.  Literature provides no evidence about whether.
 If there is no residual thyroid function, the daily replacement dose of levothyroxine is usually 1.6 g/kg body weight (typically 100– 150 g). In many.
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
1 Subclinical thyroid dysfunction and blood pressure: a community-based study John P. Walsh, Alexandra P. Bremner, Max K. Bulsara‡, Peter O’Leary, Peter.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Colorado Thyroid Disease Prevalence Study Arch.
Hypothyroidism during pregnancy
Hashimoto´s Thyroiditis
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Childhood craniopharyngioma
Figure 2 Pathophysiology of hyperglycaemia in T2DM
Nat. Rev. Cardiol. doi: /nrcardio
with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Semantic model of the active surveillance (AS) timeline
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Bimodal distribution of the glutamic acid decarboxylase
Figure 1 The Beckwith–Wiedemann spectrum
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Haematoxylin and eosin staining
Figure 1 Suggested biopsy-avoiding diagnostic pathway for coeliac disease Figure 1 | Suggested biopsy-avoiding diagnostic pathway for coeliac disease.
Figure 1 Osteosarcoma epidemiology
Figure 1 Challenges and opportunities of using omics in EDC research
Figure 3 Possible modalities for reconciliation of patient's and physician's report of symptomatic treatment-associated toxicities Figure 3 | Possible.
Figure 3 Algorithm for the determination of the clinical
Nat. Rev. Endocrinol. doi: /nrendo
Figure 2 Pharmacokinetic action profiles of rapid-acting insulins
Figure 4 Tracheal endoscopy in two patients
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 2 Serum levels of TSH and free T4 in a large series
Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.
Figure 1 Decision tree integrating the assessment,
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Evolution of multiple sclerosis
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 1 Clinical aspects of LGMD subtypes
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Gut microbial gene content and development of T1DM
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Endocrinol. doi: /nrendo
Figure 3 Global iodine status and mandatory salt iodization
Nat. Rev. Endocrinol. doi: /nrendo
HYPOTHYROIDISM.
Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.100 Figure 2 Proposed management of children with subclinical hypothyroidism Figure 2 | Proposed management of children with subclinical hypothyroidism. The initial step in the management of a child with a mild increase in TSH concentration should be confirmation of hyperthyrotropinaemia by re-evaluation of TSH levels 4–12 weeks after the first test. If an elevated TSH concentration persists, the diagnostic process should first include careful assessment of the child's history and a clinical evaluation focused on the detection of signs and symptoms suggestive of thyroid dysfunction. Thereafter, evaluation of anti-thyroid antibodies and thyroid ultrasonography will enable differentiation between autoimmune and nonautoimmune forms of subclinical hypothyroidism (SH). The subsequent management and follow-up will depend both on the aetiology and the degree of TSH elevation. The final decision on treatment should be based on the assessment of clinical symptoms or signs of mild thyroid impairment and on the risk of progression to overt hypothyroidism. FT4, free T4. Salerno, M. et al. (2016) Subclinical hypothyroidism in childhood — current knowledge and open issues Nat. Rev. Endocrinol. doi:10.1038/nrendo.2016.100